Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 41 (RPL17P41)

Target: RPL17P41
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L17 pseudogene 41 (RPL17P41) is one of numerous pseudogenes in the human genome derived from the functional RPL17 gene, which encodes a structural protein of the large (60S) ribosomal subunit[1][2][5][12]. Pseudogenes such as RPL17P41 do not produce functional proteins and are not considered canonical drug targets. There are no known disease associations, drug interactions, or biomarker roles reported for RPL17P41. Its presence in the genome reflects the common occurrence of processed pseudogenes for many ribosomal proteins but does not indicate a functional or therapeutic role[1][2][5][12].

Other names: RPL17_26_1572RPL17P41[5][2]

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 41 (RPL17P41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 41 (RPL17P41).

Explore the full profile